INCREASING STATIN USE IN DIABETICS FOR CVD PREVENTION

Código QR

INCREASING STATIN USE IN DIABETICS FOR CVD PREVENTION

Guardado en:

Detalles Bibliográficos
Autores principales:	Karsh Gaurav, Joseph Toole, Zachary Morrow, Thomas Burchfield, Annette Piotrowski, Tiffany Wong, Anand Shukla, Akshai Bhandary
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/f740a930869742219bf689932b65e3db
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Statins and Insulin Resistance
por: GM Sanvee, et al.
Publicado: (2020)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
por: Tracey M Ellimuttil, et al.
Publicado: (2021)

Effects of Statin Treatment on Patients with Angina and Normal or Nearly Normal Angiograms
por: Olivia Manfrini, et al.
Publicado: (2020)

Role of PGC-1-alpha-associated Mitochondrial Biogenesis in Statin-induced Myotoxicity
por: M Panajatovic, et al.
Publicado: (2020)

Adherence to Statin Therapy Drives Survival of Patients with Symptomatic Peripheral Artery Disease
por: J Dopheide, et al.
Publicado: (2020)

Impacts of Adipocytokines and Obesity-associated Inflammatory Markers on Apolipoprotein A-1 and B in Patients on Statin Therapy
por: M Matsuda
Publicado: (2020)

Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
por: Joe Kai, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Jose D. Torres-Peña, et al.
Publicado: (2021)

Cerebrovascular Disease and Statins
por: Luis M. Beltrán Romero, et al.
Publicado: (2021)

SERUM COPPER AND THE RISK OF CVD MORTALITY IN NORMAL WEIGHT, PRE-OBESE AND OBESE MEN IN FINLAND
por: Nzechukwu M. Isiozor, et al.
Publicado: (2021)

The Effect of Statins on the Functionality of CD4+CD25+FOXP3+ Regulatory T-cells in Acute Coronary Syndrome: A Systematic Review and Meta-analysis of Randomised Controlled Trials in Asian Populations
por: Nilofer Sorathia, et al.
Publicado: (2019)

Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
por: Marina G. Bubnova, et al.
Publicado: (2021)

Pleiotropic effects of statins: New evidences
por: Kaan Okyay
Publicado: (2021)

De-risking primary prevention: role of imaging
por: Ahmed M. Shafter, et al.
Publicado: (2021)

Statin Therapy in Very Old Patients: Lights and Shadows
por: Lidia Cobos-Palacios, et al.
Publicado: (2021)

The Role of Subcutaneous ICDs in the Prevention of Sudden Cardiac Death
por: Leah A John, et al.
Publicado: (2021)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021)

Is the increase in eltrombopag dose cause of myocardial infarction?
por: Edip Can Özgünoğlu, et al.
Publicado: (2021)

Winter Peaks in Heart Failure: An Inevitable or Preventable Consequence of Seasonal Vulnerability?
por: Simon Stewart, et al.
Publicado: (2019)

Women and Diabetes: Preventing Heart Disease in a New Era of Therapies
por: Giuseppe Galati, et al.
Publicado: (2021)

Successful management of a foreseeable and preventable complication of transcatheter valve implantation
por: Ali Rıza Akyüz, et al.
Publicado: (2021)

Increasing and Evolving Role of Smart Devices in Modern Medicine
por: Michael R Massoomi, et al.
Publicado: (2019)

Defining Left Bundle Branch Block Patterns in Cardiac Resynchronisation Therapy: A Return to His Bundle Recordings
por: Roderick Tung, et al.
Publicado: (2020)

Sodium–Glucose Cotransporter-2 Inhibitors and Heart Failure Prevention in Type 2 Diabetes
por: Muhammad Shahzeb Khan, et al.
Publicado: (2019)

Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2019)

Post-thrombotic Syndrome: Preventative and Risk Reduction Strategies Following Deep Vein Thrombosis
por: Adam M Gwozdz, et al.
Publicado: (2020)

Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
por: María Pilar Resano-Barrio, et al.
Publicado: (2020)

Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
por: Roland R Tilz, et al.
Publicado: (2020)

Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
por: Jiang Li, et al.
Publicado: (2021)

Sudden Cardiac Death: The Most Feared but Potentially Preventable Presentation of Wolff-Parkinson-White Syndrome
por: Ana Rita Pereira, et al.
Publicado: (2021)

Hypertensive Disorders in Pregnancy and the Risk of Cardiovascular Disease: A Need for Postpartum Strategies for the Primary Prevention
por: Ajay K. Gupta
Publicado: (2018)

Achieving the LDL-C goal<55mg/dL in patients of acute coronary syndrome with high intensity statin
por: Jigneshkumar Gordhanbhai Vanani, et al.
Publicado: (2021)

Sudden Cardiac Death Risk Stratification and Prevention in Chagas Disease: A Non-systematic Review of the Literature
por: Roberto Keegan, et al.
Publicado: (2020)

Increased right ventricular energy efficiency by 4DMR after harmony valve implantation
por: Jennifer Woo, et al.
Publicado: (2021)

Incisional Hernia Following Open Abdominal Aortic Aneurysm Repair: A Contemporary Review of Risk Factors and Prevention
por: Thuy-My Nguyen, et al.
Publicado: (2020)

The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis
por: Xiangwen Liang, et al.
Publicado: (2021)

A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention
por: Qian Zeng, et al.
Publicado: (2021)

Correction to: The association of reduced left ventricular strains with increased extracellular volume and their collective impact on clinical outcomes
por: Chunna Jin, et al.
Publicado: (2021)

Evaluating the Potential Effect of L-carnitine on the Prevention of AF Following Coronary Artery Bypass Graft Surgery: A Randomised Clinical Trial
por: F Dastan
Publicado: (2020)

Improvement of Fractional Flow Reserve after Percutaneous Coronary Intervention Does Not Necessarily Indicate Increased Coronary Flow
por: Rikuta Hamaya, et al.
Publicado: (2019)